Friday, 11 May 2012

Zytiga Shows Clear Survival Advantage

Zytiga shows clear survival advantage in prostate cancer patients (upper plot) when compared to placebo (lower plot).
Posted by at

2 comments:

  1. jez13 May 2012 at 14:02

    This plot shows that there is a consistent increase in survival from the moment Zytiga is started. This survival advantage continues to be seen after 20 months on this drug.

    ReplyDelete
  2. jez25 May 2012 at 11:46

    Zytiga increases average life span of prostate cancer patients from the moment it is taken.

    ReplyDelete

Subscribe to: Post Comments (Atom)